Medison Pharma has signed an agreement with Cepheid for exclusive representation of its on-demand molecular diagnostics products in Israel, GeneXpert. This unique system provide rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures.
By adding Cephid’s diagnostic products to the range that it distributes in Israel, Medison Pharma expands its hold within the local diagnostic market. Marketing activity will be conducted jointly by Medison’s Diagnostics and Pharma divisions.
Meir Jakobsohn, President of Medison Pharma, welcomes the development as a natural progression: “This agreement is another part of our continued efforts to import the most innovative diagnostic products. There is no doubt that in the future, these products will replace the conservative testing methods currently available.”
Cepheid
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company’s diagnostic systems are in the forefront of labor-saving laboratory technology.
For more information: www.cepheid.com
About Medison Pharma
Medison Pharma is a leading Israeli marketing group focused in the fields of high quality pharmaceutical, medical devices and diagnostics products. With over a decade of experience, Medison is uniquely placed to provide a complete A to Z spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli healthcare market, as well as in Romania and Slovakia.
Contact: Medison Pharma Ltd, Israel Tel: + 972-3-9250250 Email: medison@medison.co.il Site: www.medisonpharma.com
